How does darifenacin act on receptors that control bladder muscle contraction?

Darifenacin selectively blocks muscarinic M3 receptors in vitro, the main receptor subtype controlling bladder muscle contraction, although whether this selectivity provides a clinical advantage in overactive bladder is unknown.